Our promise: to save lives and improve quality of life.
Our ability to innovate and deliver life-saving medicines for patients has earned us a reputation for always putting patients first. We are driven by our promise.
CSL Behring News
CSL celebrates summer party with employees
After a break of three years due to the pandemic, the traditional CSL summer party with the motto "Together Again" finally to…
Full Year Results 2023
CSL reports 20% profit growth with a full-year net profit of $2.61 billion (1,2).
Federal Minister for Education and Research visits Behringwerke
Bettina Stark-Watzinger emphasizes importance of promoting translational science
Explainer: What Is Coagulation?
In healthy coagulation, the essential process stops the body from bleeding. It’s a finely tuned cascade that relies on severa…
Hesse's Minister President visits CSL's R&D Campus
On a campus tour, young talents from research and development gave insights into recent biomedical innovations
Rejecting Life in a Bubble
CSL partnered with industry and advocacy organizations in Germany to create a bold, visual demonstration of why primary immun…
Gene therapy for Hemophilia B available
HEMGENIX® for patients with severe and moderate Hemophilia B now available in Germany